Can HPLC be used for high-throughput vitamin D screening in clinical labs?

HPLC is a reliable method for quantifying vitamin D2 and D3, particularly in clinical and pharmaceutical settings. The Ascentis C18 column is effective for separating these fat-soluble vitamins, while isocratic HPLC methods ensure precision in tablet formulations. HPLC also enables rapid and accurate measurement of 25(OH)D2 and 25(OH)D3, making it suitable for routine clinical monitoring of vitamin D status. Coupling HPLC with mass spectrometry enhances sensitivity and specificity, especially for low-concentration samples.

Can HPLC be used for high-throughput vitamin D screening in clinical labs?

Yes, HPLC can be used for high-throughput vitamin D screening in clinical labs, but there are important considerations to maximize throughput and maintain accuracy.

Key points

• Throughput vs. complexity:
  • Conventional HPLC methods with UV or fluorescence detection can process dozens of samples per day per instrument, but may lag behind UHPLC or LC-MS-based workflows in speed.
  • For high-throughput needs, many labs favor UHPLC (ultra-high-performance) with shorter columns and faster gradients, or tandem LC-MS/MS for multiplexed assays.
• Detection strategy:
  • UV/visible detection is common for bulk vitamin D (D2, D3) in fortified foods or supplements, but clinical vitamin D status (25(OH)D2 and 25(OH)D3) often requires LC-MS/MS or immunoassays.
  • LC-MS/MS offers specificity and sensitivity for 25(OH)D isomers and can handle high sample loads with automation.
• Sample preparation:
  • Lipid-rich matrices (serum/plasma) require efficient extraction and cleanup (e.g., protein precipitation, solid-phase extraction, or liquid-liquid extraction).
  • Automating extraction and using 96-well plate formats or robotic liquid handlers can boost throughput.
• Workflow design for high throughput:
  • Use UHPLC or fast LC methods with short run times (often 2–5 minutes per sample for simple vitamin D assays; 5–15 minutes for 25(OH)D with LC-MS/MS).
  • Implement on-line or semi-automated sample preparation in 96-well plates.
  • Employ gradient methods and robust column chemistries (C18 or M84-type columns) optimized for minimal carryover and reproducible calibration.
  • Include internal standards (e.g., deuterated 25(OH)D) to improve precision across batches.
  • Use software for automated peak integration, calibration, and quality control.
• Considerations and trade-offs:
  • Specificity: Immunoassays are fast and high-throughput but can suffer from cross-reactivity; LC-MS/MS provides higher specificity, which is valuable in screening and confirmatory contexts.
  • Cost and maintenance: LC-MS/MS systems have higher upfront and maintenance costs but reduce per-sample time with multiplexing; UHPLC setups reduce run times but require precise instrumentation.
  • Validation: High-throughput workflows must be validated for accuracy, precision, linearity, carryover, and reference intervals, including proficiency testing.
• Practical setup approaches:
  • Option A: LC-MS/MS-based high-throughput screening for 25(OH)D with automated sample prep and 96-well plate workflows.
  • Option B: UHPLC with faster isocratic or short-gradient methods for vitamin D2/D3 if focusing on fortified products or non-clinical matrices.
    Option C: Combine LC-MS/MS for confirmation of borderline results identified by a high-throughput screening method.
• Performance metrics to monitor:
  • Throughput (samples per day per instrument)
  • Run time per sample
  • Total turnaround time
  • Inter-run and intra-run precision (CV%)
  • Accuracy against reference methods or reference materials
  • Carryover and stability